Clinical Trial

Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease

Study acronym: INDOS-B
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to observe the safety and tolerability of Breztri aerosphereTM as maintenance treatment in Indian patients with moderate to severe COPD.
Protocol Amendment History 1 change
notable Trial sites expanded: 1 -> 5 locations 2026-07-23
Trial Details
NCT Number NCT06531798
Lead Sponsor AstraZeneca
Conditions Moderate to Severe COPD
Enrollment 150 participants
Start Date 2026-01-30
Primary Completion 2026-10-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-22